Filing Flows › Kewaunee Scientific (KEQU) › Q1 FY27 › vs Q4 FY26
Kewaunee Scientific (KEQU) Q1 FY27 vs Q4 FY26 (quarter over quarter)
Kewaunee Scientific's revenue fell $5.1M (-7%) from $71.4M in Q4 FY26 to $66.3M in Q1 FY27. Gross margin 29.6% against 29.8% (-0.1 pts).
Kewaunee Scientific, Q1 FY27: revenue $66.3M (-7% year over year), operating margin 4.8%, net earnings $1.7M, operating cash flow $2.0M. The chart draws each line against Q4 FY26, the increases inside each band.
Margins
| Q1 FY27 | Q4 FY26 | Change | |
|---|---|---|---|
| Gross margin | 29.6% | 29.8% | -0.1 pts |
| Operating margin | 4.8% | 7.3% | -2.5 pts |
| Net margin | 2.6% | 4.7% | -2.2 pts |
| Free cash flow margin | 1.8% | 6.3% | -4.5 pts |
Every line
| Line | Q1 FY27 | Q4 FY26 | Change | % |
|---|---|---|---|---|
| Revenue | $66.3M | $71.4M | −$5.1M | -7% |
| Gross profit | $19.6M | $21.2M | −$1.6M | -8% |
| Cost of revenue | $46.7M | $50.2M | −$3.5M | -7% |
| Operating profit | $3.2M | $5.2M | −$2.1M | -39% |
| Operating expenses | $16.5M | $16.0M | $452K | +3% |
| Pre-tax earnings | $2.6M | $4.8M | −$2.2M | -46% |
| Other expense, net | $598K | $460K | $138K | +30% |
| Net earnings | $1.7M | $3.4M | −$1.7M | -50% |
| Minority interests | $137K | $304K | −$167K | -55% |
| Income tax | $717K | $1.1M | −$347K | -33% |
| Operating cash sources | $5.2M | $5.4M | −$249K | -5% |
| Depreciation | $1.6M | $1.6M | $36K | +2% |
| Share-based compensation | $1.9M | $502K | $1.4M | +278% |
| Working capital & other | $3.2M | −$15K | $3.2M | — |
| Operating cash flow | $2.0M | $5.5M | −$3.5M | -64% |
| Free cash flow (OCF − capex) | $1.2M | $4.5M | −$3.3M | -73% |
| Capital expenditures | $772K | $928K | −$156K | -17% |
Questions
How much did Kewaunee Scientific's revenue grow quarter over quarter in Q1 FY27?
Kewaunee Scientific's revenue fell $5.1M (-7%) from $71.4M in Q4 FY26 to $66.3M in Q1 FY27. Gross margin 29.6% against 29.8% (-0.1 pts).